From the academyAAD consensus statement on psoriasis therapies*
References (0)
Cited by (104)
A review of phototherapy protocols for psoriasis treatment
2011, Journal of the American Academy of DermatologyCitation Excerpt :The manner in which phototherapy fits into the total package of psoriasis treatment with other standard modalities, such as topical and systemic agents, is only now becoming elucidated. However, many current guidelines still do not favor one modality (biologics/systemic agents/phototherapy) over another; all are equally recommended.1-5 Some guidelines advocate narrowband ultraviolet B (NB-UVB) phototherapy as first-line treatment when available, citing a number of advantages of NB-UVB over other modalities.
Treatment of moderate-to-severe psoriasis in clinical practice: A survey of spanish dermatologists
2010, Actas Dermo-SifiliograficasPsoriasis
2010, Current Clinical Medicine: Expert Consult Premium Edition - Enhanced Online Features and PrintA Description of Treatment Patterns of Psoriasis by Medical Providers and Disease Severity in US Women
2021, Journal of Psoriasis and Psoriatic Arthritis
- *
A listing of all summit participants may be found at the end of this article. This document is the work product of The Psoriasis Therapies Educational Summit meeting that was held in Louisville, Ky, November 2-3, 2002. The Breakout group responsible for this document was chaired by Gerald D. Weinstein, MD, and co-chaired by Craig A. Elmets, MD. Other members of this group included Irwin M. Braverman, MD, David E. Cohen, MD, Alice B. Gottlieb, MD, PhD, Richard G. B. Langley, MD, Craig L. Leonardi, MD, Alan Menter, MD, Seth J. Orlow, MD, PhD, and Guy F. Webster, MD, PhD. A first draft was presented to the entire group and the document was then circulated for comments.